MiMedx Group, Inc. Debt Instrument, Fair Value Disclosure
MiMedx Group, Inc. (MDXG) had Debt Instrument, Fair Value Disclosure of $5.17 million as of 2012-12-31, per its 10-K filed 2013-03-15.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2013-03-15
- 2012-12-31: Debt Instrument, Fair Value Disclosure $5.17M.
- 2012-09-30: Debt Instrument, Fair Value Disclosure $4.67M.
- 2012-06-30: Debt Instrument, Fair Value Disclosure $5.29M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2012-12-31 | $5.17M 10-K · filed 2013-03-15 |
| 2012-09-30 | $4.67M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $5.29M 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |